• / Free eNewsletters & Magazine
  • / My Account
Home>Regions>Israel

Israel

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

    Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

  2. Joseph Israel Named CEO William Monteleone Named SVP of M&A and Remains on Board of Directors

    Joseph Israel Named CEO William Monteleone Named SVP of M&A and Remains on Board of Directors

  3. Alon Blue Square Israel Ltd. Announces Resignation of Co-Executive Officer, Limor Ganot

    Alon Blue Square Israel Ltd. Announces Resignation of Co-Executive Officer, Limor Ganot

  4. U.S. Court Rejects Vale Bid to Dismiss Rio Tinto Lawsuit

    U.S. Court Rejects Vale Bid to Dismiss Rio Tinto Lawsuit

  5. U.S. Court Rejects Vale Bid to Dismiss Rio Tinto Lawsuit

    U.S. Court Rejects Vale Bid to Dismiss Rio Tinto Lawsuit

  6. Xaviel Niel to Buy Orange Switzerland -- Update

    Xaviel Niel to Buy Orange Switzerland -- Update

  7. Research and Markets: Construction Stone Market in Israel : Business Report 2014

    Research and Markets: Construction Stone Market in Israel : Business Report 2014

  8. ICL To Divest Rhenoflex Business

    ICL To Divest Rhenoflex Business

  9. BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office

    BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office

  10. UPDATE: These entitled tech bullies are ruining Silicon Valley

    UPDATE: These entitled tech bullies are ruining Silicon Valley

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.